Learn about our work and hear what our clients have to say.

Nkarta Collaboration Achieves Cost Effective Manufacturing in Tight Timelines
Find out more about why Nkarta chose CCRM as its contract development and manufacturing organization (CDMO) partner for clinical phase manufacturing of a natural killer cell product.
“We’ve found an ongoing partner [in CCRM]” – Dr. Ralph Brandenberger, SVP Technical Operations, Nkarta
DiscGenics Collaboration Successfully Develops Allogeneic Therapy to Enable Efficient Manufacturing
Learn about how DiscGenics worked with CCRM to establish a novel process.
“[The team] really helped us get to where we are today.” – Dr. Lara Ionescu Silverman, PhD, Senior Director, Research and Development, DiscGenics
Collaborative Relationship Allows Avectas to Accelerate the Translation of SOLUPORE™ into the Clinic
Learn how Avectas, a cell engineering technology company, worked with CCRM to develop a unique intracellular delivery platform to enable ex vivo cell-based therapies.

“[CCRM’s] culture and adaptive nature, flexibility and communication were excellent.” – Edel O’Toole, Senior Director Project & Vendor Management, Avectas

The Cystic Fibrosis (CF) Canada Program in Individualized Therapy (CFIT)
The Cystic Fibrosis (CF) Canada Program in Individualized Therapy (CFIT)
Learn how our team collaborated with an academic lab at SickKids to establish a bank of 100 patient-derived iPSC lines and isogenic controls.

“CCRM has shared valuable expertise with our team, benefiting the project overall.”
– Dr. Christine Bear, The Hospital for Sick Children

Process Development for Scaled-up hESC/hiPSC Manufacturing
Process Development for Scaled-Up hESC/hiPSC Manufacturing
Read about an optimized 14-day manufacturing workflow that produces >1010 cells.
Manufacturing of Pluripotent Stem Cell-Derived Cardiomyocytes for Pre-Clinical Animal Studies
Manufacturing of Pluripotent Stem Cell-Derived Cardiomyocytes for Pre-Clinical Animal Studies
Find out how CCRM worked with a member of the local academic community to translate a cell therapy protocol from bench-scale to bioreactor.
Animal Component Free (ACF) Media Development for Cell Therapies
Animal Component Free (ACF) Media Development for Cell Therapies
Understand how ACF media can achieve comparable performance to serum containing media.